pabinafusp alfa   Click here for help

GtoPdb Ligand ID: 11772

Synonyms: IZCARGO® | JR-141 | JR141
Approved drug
pabinafusp alfa is an approved drug (Japan (2021))
Compound class: Antibody
Comment: Pabinafusp (JR-141) is a fusion protein of the Fab domains of an anti-transferrin receptor monoclonal and the enzyme iduronate 2-sulfatase (IDS; P22304) [5], an enzyme that is deficient in patients with the lysosomal storage disease mucopolysaccharidosis type II (MPS II; Hunter syndrome) [1-2]. It is an intravenously administered enzyme replacement therapy. The anti-transferrin receptor component facilitates receptor-mediated movement of the fused enzyme across the blood-brain barrier [4].
Classification Click here for help
Compound class Antibody
Approved drug? Yes (Japan (2021))
International Nonproprietary Names Click here for help
INN number INN
10995 pabinafusp alfa
Synonyms Click here for help
IZCARGO® | JR-141 | JR141
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 914
Other databases
GtoPdb PubChem SID 458923807
Search PubMed clinical trials pabinafusp alfa
Search PubMed titles pabinafusp alfa
Search PubMed titles/abstracts pabinafusp alfa